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Abstract: Peroxisome proliferator activated receptor γ co-activator 1α 
(PGC-1α) is a regulator of mitochondrial metabolism and reactive oxygen 
species (ROS) that is known to play a relevant role in angiogenesis. 
Aims: This study aims to investigate the role of ROS on the regulation by 
PGC-1α of angiogenesis. Methods and Results: We found that endothelial 
cells (ECs) from mice deleted for PGC-1α display attenuated adhesion to 
the extracellular matrix, together with slower and reversible spreading. 
Structural analysis demonstrates unstable formation of focal adhesions, 
defective cytoskeleton reorganization in response to cellular matrix 
adhesion, cell migration and cell-cell adhesion. Confluent cultures 
showed also a reduction of membrane bound VE-cadherin, suggesting 
defective inter-cellular junction formation. Functional consequences 
included impaired directional migration, and enhanced tip phenotype in 
aortic explants sprouting assays. At the molecular level, PGC-1α-deleted 
ECs exhibit a constitutive activation of the vascular endothelial growth 
factor-A (VEGF-A) signaling pathway and a defective response to VEGF-A. 
All these alterations are partially reversed by administration of the 
antioxidant EUK-189. The contribution of mitochondrial ROS and NOX 
activation was confirmed using a mitochondrial targeted antioxidant 
(MitoTEMPO) and a NOX inhibitor (VAS-2870). These results indicate that 
elevated production of ROS in the absence of PGC-1α is a key factor in 
the alteration of the VEGF-A signaling pathway and the capacity of 
endothelial cells to form stable interactions with other endothelial 
cells and with the extracellular matrix. Our findings show that PGC-1α 
control of ROS homeostasis plays an important role in the control of 
endothelial response to VEGF-A. 
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Madrid, 15
th
 of January, 2016 
 
Dear Editor, 
 
We respectfully submit the revised version of the manuscript, entitled “Regulation of 
endothelial dynamics by PGC-1 relies on ROS control of VEGF-A signaling” 
Manuscript No.: FRBM-D-15-00688 to be considered for publication in as an original 
article in Free Radical Biology & Medicine. In this revised version we hope to have 
fully addressed all the editor’s and reviewer’s criticisms to the original manuscript. We 
would like to thank the reviewers for their contribution to the improvement of the 
quality of the manuscript. 
 
In this study we show that PGC-1-deficient endothelial cells interact poorly with ECM 
and neighboring cells, and exhibit a reduced response to VEGF-A. Further analysis 
suggested that the observed phenotype could be due to the excessive ROS levels, 
previously reported to be a hallmark of PGC-1 inactivation. Indeed, antioxidant 
treatment reverted both the insensitivity to VEGF-A stimulation and partially corrected 
the phenotype, indicating that ROS-dependent alterations in VEGF-A signaling are 
likely to be important in the vascular instability associated with the absence of PGC-1. 
  
PGC-1 has been previously shown regulate angiogenesis, however vascular problems 
relating to PGC-1 activity were thought to reflect PGC-1 regulation of VEGF-A 
expression. Furthermore, it has been proposed that PGC-1 makes endothelial cells 
insensitive to pro-angiogenic factors and works essentially as an anti-angiogenic factor 
itself, in endothelial cells. Importantly, we show that PGC-1 plays a crucial role in the 
formation of stable vascular structures and its activity is necessary for an effective 
response to VEGF-A signaling. Thus, we propose that the vascular anomalies found in 
PGC-1-/- mice relate to the association of cell quiescence with ROS control. Oxidative 
metabolism reduces ROS levels and favors cell quiescence and in the case of the 
vascular endothelium, inability to induce it in the absence of PGC-1 results in vascular 
instability. 
 
We believe our results are of interest to the readership of Free Radical biology & 
Medicine since they suggest that many of the microvascular anomalies that are 
characteristic of metabolic dysfunctions, and in particular of diabetic retinopathy, may 
be related to the low levels of PGC-1 in the vascular endothelium. Further, our 
findings provide new mechanistic insights into vascular biology and disease, because in 
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patients with metabolic disease, reduced PGC-1 levels are likely to cause a ROS-
dependent inactivation of key VEGF-A signaling pathway nodes, and this inactivation 
can be relevant in the development of microvascular complications. 
 
Below we provide a detailed account of all the changes made to the manuscript in 
response to the reviewers’ comments. We believe this new version answers the 
reviewer’s criticisms, and that the scientific interest of the work has been increased. We 
believe that our study makes an important contribution toward understanding the 
connections between metabolism and oxidative stress. 
 
Sincerely yours, 
María Monsalve 
Maria Monsalve, PhD 
Instituto de Investigaciones Biomédicas Alberto Sols 
Dept. Metabolism and Cell Signalling 
Arturo Duperier, 4 
28029-Madrid (Spain) 
Phone: 915854471 
Fax: 915854401 
e-mail: mpmonsalve@iib.uam.es 
 
Point by point answer to reviewers: 
 
Reviewer 2:  
 
1.- The authors used a NOX inhibitor rather than an antioxidant to confirm their findings.   
 
Answer. We have no used a mitochondrial-targeted antioxidant (MitoTEMPO) to evaluate the 
contribution of mitochondrial ROS. The results have been incorporated in the new Figure 6. 
 
2.- This data was buried in a Supplement and not even mentioned in the Abstract.  
 
Answer. The new data, together with the previous experiments on NOX activity are now part of 
Figure 6. The main conclusión has been included in the Abstract and reads: “The contribution of 
mitochondrial ROS and NOX activation was confirmed using a mitochondrial targeted 
antioxidant (MitoTEMPO) and a NOX inhibitor (VAS-2870).” 
 
3.- The blots using the NOX inhibitor were not at all convincing for the data shown. There 
appeared to be artifacts on the figures as well. The quantitation on the bands is not convincing. 
 
  
Answer. We have the extended text in the results section and in the Figure 6 legend aiming to 
clarify the results and the conclusions. The new text reads as follows: 
 
PGC-1 has been shown to induce the expression of several mitochondrial antioxidant proteins, 
and its absence results in enhanced mitochondrial superoxide levels. Concomitantly, PGC-1 
also regulates the expression of important extra-mitochondrial antioxidants, like catalase. In 
order to validate the contribution of mitochondrial ROS to the observed alteration in VEGF 
signaling, we treated PGC-1-/- MLEC with a mitochondria-targeted SOD mimetic, 
MitoTEMPO and evaluated the effect on VEGF-A signaling. We found a significant reduction 
in the basal levels of phosphorylation of VEGFR2 and AKT, as well as a reduction in the basal 
levels of NICD (Fig. 6A, central panel). VEGF-A treatment also resulted in an enhanced fold 
induction of VEGFR2 and AKT phosphorylation, as well as in the levels of NICD upon 
stimulation (Fig. 6A, bottom panel). These results suggest that there is a relevant contribution of 
mitochondrial ROS production to the observed phenotype. 
 
Finally, since hydrogen peroxide dependent inactivation of VEGF signaling pathway has been 
proposed to be mediated by NOX activity, we tested whether NOX inhibition would be able to 
restore VEGF-A signaling in PGC-1-/- cells, and we found that pretreatment with the general 
NOX inhibitor VAS-2870 also resulted in significant reduction in the basal levels of 
phosphorylation of VEGFR2 and AKT and an enhanced sensitivity (fold induction) of the 
VEGFR2 receptor to VEGF-A dependent phosphorylation, that correlated with and enhanced 
AKT phosphorylation, supporting the involvement of NOX activity (Fig. 6B). 
 
Figure 6. Both detoxification of mitochondrial ROS and NOX inhibition restores VEGF signaling in 
PGC-1-/- MLECs. PGC-1-/- MLECs where pre-treated with the mitochondria-targeted SOD mimetic 
MitoTEMPO (10 M) for 3 h (A, n=5) or with a general NOX inhibitor (VAS-2870, 20 M) for 2h (B, 
n=3), then VEGF-A was added and downstream signaling (VEGFR2, NICD and AKT) was analyzed by 
western blot (n=5). Top panels show representative western blots. Central panels show the quantitative 
analysis of data at time 0, prior to VEGF-A addition. The bottom panels show the fold induction upon 
VEGF-A addition, values are normalized for those at time 0, that have been assigned the arbitrary value 
of 1. Data are means ±SD (*) p ≤ 0.05 vs. control. 
 
4.- The bands in the new figures were not labeled.  
 
Answer. We have now labeled the bands as suggested. 
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Abstract 
 
Peroxisome proliferator activated receptor  co-activator 1 (PGC-1) is a regulator of mitochondrial 
metabolism and reactive oxygen species (ROS) that is known to play a relevant role in angiogenesis. 
Aims: This study aims to investigate the role of ROS on the regulation by PGC-1 of angiogenesis. 
Methods and Results: We found that endothelial cells (ECs) from mice deleted for PGC-1 display 
attenuated adhesion to the extracellular matrix, together with slower and reversible spreading. 
Structural analysis demonstrates unstable formation of focal adhesions, defective cytoskeleton 
reorganization in response to cellular matrix adhesion, cell migration and cell-cell adhesion. Confluent 
cultures showed also a reduction of membrane bound VE-cadherin, suggesting defective inter-cellular 
junction formation. Functional consequences included impaired directional migration, and enhanced 
tip phenotype in aortic explants sprouting assays. At the molecular level, PGC-1-deleted ECs exhibit 
a constitutive activation of the vascular endothelial growth factor-A (VEGF-A) signaling pathway and 
a defective response to VEGF-A. All these alterations are partially reversed by administration of the 
antioxidant EUK-189. The contribution of mitochondrial ROS and NOX activation was confirmed 
using a mitochondrial targeted antioxidant (MitoTEMPO) and a NOX inhibitor (VAS-2870). These 
results indicate that elevated production of ROS in the absence of PGC-1 is a key factor in the 
alteration of the VEGF-A signaling pathway and the capacity of endothelial cells to form stable 
interactions with other endothelial cells and with the extracellular matrix. Our findings show that 
PGC-1 control of ROS homeostasis plays an important role in the control of endothelial response to 
VEGF-A. 
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Introduction 
 
While caloric restriction boost in the organism the use of mitochondria as a source of ATP, 
overfeeding tends to decrease the use of mitochondria as a source of ATP and leads to a 
preponderance of anaerobic glycolysis in a variety of tissues [1, 2]. This decrease in mitochondrial 
function is mediated by the down-regulation and functional inactivation of key metabolic regulators 
like the transcriptional coactivator Peroxisome proliferator-activated receptor gamma coactivator-1-
alpha (PGC-1) [3, 4], a master regulator of genes involved in oxidative metabolism. Loss of PGC-1 
activity results in an increase of mitochondrial-derived reactive oxygen species (ROS) [5], and 
elevated ROS levels (oxidative stress) have been found in the majority of vascular complications 
associated with metabolic disorders.  
 
The importance of protecting the body from the most common metabolic disorders, including obesity 
and type 2 diabetes cannot be overstated, and their prevalence continues to increase yearly and World-
wide. Dysfunctions of the human vascular tree are the major source of morbidity and mortality. 
Generally, the damaging effects can be separated into macrovascular (coronary artery disease, 
peripheral arterial disease, and stroke) and microvascular (nephropathy, neuropathy, and retinopathy) 
injury [6]. Diabetic retinopathy is one of the most common microvascular complications of diabetes, 
and is a leading cause of ∼10,000 new cases of blindness every year in the United States alone [7].  
 
Reduced mitochondrial activity has been amply reported as a hallmark of type 2 diabetes [8, 9] and 
reduced activity of PGC-1 in diabetic subjects has been show in several tissues including the skeletal 
muscle [2]. However, elevated mRNA levels of PGC-1 have been found in the liver of type 2 
diabetic subjects and it has been proposed that elevated PGC-1 in diabetic subjects increases 
gluconeogenesis pointing to a putative detrimental role of PGC-1 in type 2 diabetes. More recently, it 
has also been proposed that PGC-1 activation in the retina may be involved in type 2 diabetic 
retinopathy, through the induction of VEGF-A levels [10, 11]. 
 
Previous results from our group showed that PGC-1 was present in vascular endothelial cells (ECs), 
and its levels were reduced by hyperglycemia. Furthermore, PGC-1 could coordinate ECs oxidative 
metabolism and antioxidant capacity [12], suggesting that PGC-1 could play a key role in the 
physiology of the vascular endothelium. ROS (ie hydrogen peroxide) are acknowledged as important 
signaling mediators regulating cell proliferation and migration [13]. Additional studies from our 
laboratory showed that, at least in vitro, PGC-1 was a negative regulator of EC migration indicating 
that PGC-1 activity could be important for the control of vascular stability and angiogenesis. 
Accordingly, in response to angiogenesis mediators, PI3K-AKT activation resulted in the down-
regulation of PGC-1 leading to increased mitochondrial ROS levels (oxygen superoxide and 
hydrogen peroxide) and enhanced EC migration [14]. More recently, it has been shown that PGC-1 
deficient mice show defective induction of VEGF-A in response to ischemia and impaired 
angiogenesis [15, 16]. However, the molecular mechanisms involved, other than altered endothelial 
cell migration where largely unknown. Importantly, hydrogen peroxide is increasingly recognized as a 
regulator of VEGF-A signaling [17, 18]. Since VEGF-A activity is a crucial factor in the regulation of 
endothelial motility and interaction with other cells and with the basal membrane. In this study we 
aimed to characterize the role of PGC-1 as a regulator of ROS homeostasis in the control of 
endothelial adhesion dynamics and VEGF-A signaling. 
 
We found that ECs deleted for PGC-1 had a reduced capacity to interact with each other and with the 
extracellular matrix, and were unable to form angiotubes in vitro. Furthermore, PGC-1 deleted ECs 
moved faster but in a non-coordinated manner, and displayed a tip-like phenotype. Importantly, their 
response to VEGF-A was impaired. These characteristics would be consistent with a reduced capacity 
to form a stable vasculature. Crucially, this phenotype could be partially rescued by antioxidant 
treatment, suggesting that excessive hydrogen peroxide production is likely to play an important role 
in vascular stability. 
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Material and Methods 
 
Animal handling. C57BL6 PGC-1+/+ and PGC-1-/- were used. C57BL/6 PGC-1-/- mice were 
originally provided by Dr. Bruce Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School) 
and following embryo transfer, a colony was established at the CNIC and IIB SPF animal facilities. 
Animal experimental protocols were approved by the Institutional Animal Care and Use Committee of 
the CNIC (N
o
 PI 19/09) and the CSIC (SAF2012-37693). All procedures conformed to the Declaration 
of Helsinki and the NIH guidelines for animal care and use (NIH publication No. 85-23). Animals 
were maintained at a constant temperature of 21+/- 1°C and on a 12-hour light–dark cycle. Animal 
experimental protocols were approved by the Institutional Animal Care and Use Committee of the 
CNIC and the CSIC. All procedures conformed to the Declaration of Helsinki and the NIH guidelines 
for animal care and use (NIH publication No. 85-23). Mice were euthanized by carbon dioxide 
inhalation or cervical dislocation. 
 
Cell culture. Bovine Aortic Endothelial Cells (BAECs) and Mouse Lung Endothelial Cells (MLECs) 
were obtained and cultured as described [14]. Bovine Aortas were obtained from an authorized 
slaughterhouse (El Matadero S.C.M., Colmenar Viejo, Madrid, Spain). Adenovirus overexpression 
and infection protocols have been described [19]. 
 
Cell-attachment and cell spreading assays. Experiments were performed in triplicate in 96-well plates. 
Wells were coated with fibronectin (1 µg/ml, Sigma) or collagen I (30 g/ml, INAMEN Biomaterials) 
and then blocked for 90 minutes with 1% heat-denatured BSA in PBS. MLECs were plated at 9x10
4
 
cells/well for up to 1 hour, washed, fixed with 3% PFA for 1 min, permeabilized with 2% methanol 
for 3 min, stained with 0.5 % crystal violet in 20 % methanol for 2 min, washed with water and 
examined by brightfield microscopy (Nikon Eclipse 90Ti with objectives: Plan Fluor 4x/0.13 Ph1 DL, 
Plan Fluor 10x/0.30 Ph1 DLL, Plan Fluor ELWD 40x/0.60 Ph2 DH). Cells were classified as spread if 
the nucleus and cytoplasmic extensions were distinguishable.  
 
Time lapse video imaging of scratch assays. Scratch assays were performed as previously described 
[14], and images were taken every 20 min for up to 30 h with a Nikon Eclipse Ti microscope 
(objective 4x). 
 
Sprouting angiogenesis on aortic explants. Assays were performed as described [20]. 
 
Immunofluorescence and phalloidin staining. MLECs grown on coverslips were fixed with 3.6% PFA, 
permeabilized with 0.1% Triton X-100, blocked with 2% BSA and then incubated consecutively with 
primary antibody (-p-paxillin or -VE-cadherin) and a secondary antibody (IgG rabbit ALEXA-
488 conjugate), or stained with FITC-phalloidin (Molecular Probes) in PBS for 1 h. Cells were then 
counterstained with DAPI, mounted and examined with a confocal microscope (Nikon A1R, objective 
40x) for VE-cadherin or a TIRF microscope (Leica, objective HCX Pl Apo 100x 1.46 Oil) for p-
paxilin. 
 
In vitro endothelial cell tube formation. Assays were performed essentially as described[21]. 96-well 
plates were coated with 40 l of growth factor reduced (GFR) BD Matrigel per well. MLECs (17000 
cells) resuspended in 100 l of tissue culture media with 2% Horse Serum (HS) and containing, as 
indicated, 50 ng/ml of VEGF-A, were seeded per well. Images were taken every 20 min for up to 48 h 
with a Nikon EclipseTi microscope. 
 
Vascular Endothelial Growth Factor-A (VEGF-A) treatment. MLECs were grown to confluence in 
DMEM-F12 medium with 20% FBS. Following overnight serum starvation o/n (0.5% FBS) the cells 
were first pre-incubated with 10 M EUK-189 or 20 M VAS-2870 for 2 h, or 10 M MitoTEMPO 
for 3 h as indicated and then incubated with 12.5 ng/ml of VEGF for up to 4 h and harvested. 
 
Protein extraction and Western blotting. Protein extraction was as previously described [19]. Protein 
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extracts 20-25 g of were resolved by electrophoresis in 6-12% SDS-PAGE gels, followed by transfer 
to PVDF Hybond-P membranes (Amersham Biosciences) and incubated with specific antibodies 
against HIF-1 (610958, BD Transduction Laboratories), VEGF-A, (VG-1, Santa Cruz), VEGF-R2 
(55B11, 1:1000), P-VEGFR2 ( 2471, 1:1000), NICD (4147, 1:1000), AKT (2920) and 
phosphorylated AKT-Ser
473
 (4060) (1:2000), all from Cell Signaling Technology®, and -actin (A 
5441, Sigma). -actin was used as a loading control. 
 
Image analysis. ImageJ software was used to analyze western blots, for global determination of areas 
in inmunofluorescent images, and membrane/cytosol ratios of VE-cadherin. In vitro angiogenesis 
images were analyzed using the Angiogenesis Analyzer tool for Image J developed by Gilles 
Carpertier.  
 
Statistics. Data are expressed as means ±SD. Statistical significance was evaluated by analysis of 
variance or a nonparametric test, as appropriate. Values were considered statistically significant at p < 
0.05. n ≥ 3 in all experiments. The number of independent experiments, for each particular 
experiment, is indicated in the corresponding figure legends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
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PGC-1 enhances endothelial adhesion to the extracellular matrix 
To evaluate the role of PGC-1 during ECs interaction with the extracellular matrix (ECM), MLECs 
obtained from PGC-1-/- and PGC-1+/+ mice were allowed to adhere to collagen I or fibronectin-
coated slides for 30 min and were subsequently counted. These substrates where selected because they 
are the most commonly used substrates for endothelial cells grown in vitro. Compared with wild type 
MLECs, significantly fewer PGC-1-/- MLECs adhered to both fibronectin and collagen I (Fig.1A, top 
panel); although adherence of both was greater to fibronectin than to collagen matrix. To determine 
whether PGC-1-/- MLECs adhered more slowly to ECM or with less stability, a time course analysis 
using fibronectin was performed, and attached cells were counted. At 20 min, the number of wild-type 
MLECs attached reached a maximum while PGC-1-/- MLECs continued to adhere after 30 min (Fig. 
1A, bottom panel), suggesting that matrix attachment might be less efficient in PGC-1-/- MLECs. 
To determine whether the absence of PGC-1 reduced the initial contacts only, or also had an effect 
on the formation of stable interactions with the matrix, we evaluated the cell spreading process by 
determining the number of attached cells that had spread 1 h after plating. Results showed that 
whereas greater than 80 % of wild-type MLECs had spread onto the matrix, approximately 45 % of 
PGC-1-/- MLEC had done so (Fig. 1B), suggesting that PGC-1 deficiency reduced the formation of 
stable adhesions.  
 
Figure 1. Endothelial cell adhesion and spreading dynamics are regulated by PGC-1. Wild-type and PGC-
1-/- MLECs were seeded on plates coated with fibronectin or collagen I and allowed to adhere for up to 30 min 
(A) or to spread for up to 2 h (B). Cells were washed fixed, bright field visualized on a microscope and counted. 
Left panels show images from representative experiments. Right panels show the quantifications. Data are means 
+SD (*) p ≤ 0.05 vs. control. A, top panel) n=9. A, bottom panel) n=8. B) n=6. 
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Absence of PGC-1 results in unstable adhesion and spreading 
To corroborate these results, we monitored the cell adhesion-spreading process using time-lapse video 
imaging of cell movements for 1 h after attachment to collagen I matrix. In contrast to wild-type 
MLECs, which displayed very limited motility after initial spreading, PGC-1-/- MLECs not only 
moved faster once attached, as has been previously described [14], but also showed incomplete and 
fully reversible spreading and detachment (Fig. 2A). Collectively, these results suggest that both the 
initial interaction with the matrix and also the formation of stable focal adhesions may be impaired in 
PGC-1-/- ECs. 
 
To assess whether PGC-1 regulated the formation of focal adhesions, we next analyzed the focal 
adhesion complex-component paxillin. Paxillin is activated and phosphorylated by focal adhesion 
kinase (FAK) in response to integrin signaling, resulting in the formation of a focal adhesion complex. 
However, it must be dephosphorylated to allow the stabilization of the focal adhesion, and therefore 
can be used to monitor the turnover rate of newly formed focal adhesions. Analysis of phospo (p)-
paxillin in MLECs that had been allowed to attach for 30 min, revealed that p-paxillin was localized to 
the tips of spreading filopoidia in wild-type MLECs (Fig. 2B). In contrast, PGC-1-/- MLECs 
displayed intense p-paxillin staining throughout the cell periphery, suggesting a random and highly 
active turnover of focal adhesions. These findings imply that the reduced adhesion capacity of PGC-
1-/- MLECs is not due to an inability to form focal adhesion complexes but rather might be the 
consequence of an excessive FAK activity and high turnover rate [22] 
 
Defective cytoskeleton dynamics in absence of PGC-1 
Cellular interactions with matrix components triggers stress fiber-formation of the polymerized actin 
cytoskeleton. In wild-type MLECs, F-actin was found concentrated in the extending filopodia of 
spreading cells 1 h after plating, and stress fibers were fully formed 2 h following plating (Fig 2B). In 
contrast, MLECs from PGC-1-/- mice exhibited dispersed F-actin foci throughout the cell periphery, 
and no stress fibers were detected even after 2 h (Fig 2B). To determine if this disorganization was a 
consequence of a deficient cell adhesion process, or could also be conspicuous in other situations, we 
analyzed the actin cytoskeleton of migrating and confluent cell cultures. Interestingly, while actin 
filaments reorganized in wild-type cells, and were about 2.5x more concentrated in the leading edge 
than in the retracting edge, this was barely detectable in PGC-1-/- MLECs (Fig. 2C). In confluent 
cultures, actin filaments are normally more concentrated in the cellular periphery than in the cytosol. 
Remarkably, this difference was more marked in PGC-1-/- MLEC, while mean cytosolic phalloiding 
stain was lower PGC-1-/- MLEC (Fig. 2C). These two characteristics could be related to the higher 
mobility of these cells. Moreover, PGC-1-/- MLECs were, on average, approximately 50% larger than 
wild-type counterparts, possibly a consequence of actin disorganization (Fig. 2D). 
 
Endothelial cells show reduced formation of adherens junctions in absence of PGC-1 
To test whether intercellular junctions were also affected by the absence of PGC-1, we analyzed VE-
cadherin staining in confluent cultures. VE-cadherin plays a major role in the organization of 
intercellular adherens junctions in ECs. PGC-1-/- MLECs exhibited a reduction in VE-cadherin levels 
relative to wild-type cells; also, staining was not continuous and gaps could be detected together in 
zones where the membranes were not in direct contact despite the confluence of the culture (Fig. 2D, 
Supp. Fig. 1). 
 
 
 
 
 
 
 
 
 
Fig. 2 
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Figure 2. PGC-1-/- MLEC form unstable cell-matrix and cell-cell contacts. A) Time-lapse bright field video 
images of live cells that have been allowed to adhere for 1 h. Images show the dynamics of representative cells at 
5 min intervals for 1 h (n=3). B) Focal adhesion dynamics was analyzed by IF staining of cells with a p-paxillin 
antibody and polymerized actin filaments with phalloidin. Focal adhesions were visualized using a TIRF 
microscope (n=3). C) Wild-type and PGC-1-/- MLECs actin filaments stained with phalloidin in sub-confluent 
and confluent MLECs and visualized with a fluorescence microscope (n=3). D) IF of VE-cadherin of confluent 
wild-type and PGC-1-/- MLECs on a fibronectin-coated plate. Nuclei were stained with DAPI (n=3). Data are 
means +SD (*) p ≤ 0.05 vs. control. 
PGC-1 regulates endothelial cell coordination during migration 
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To assess how these deficiencies could impact on cell migration processes, we monitored cell motility 
using in vitro scratch assays and time-lapse video imaging. Whereas wild-type cells appeared to 
stream together as they migrated, we noted that the absence of PGC-1 resulted not only in an 
accelerated cell movement as already described [14], but also on a pronounced tendency to disperse 
over a larger area (Fig. 3A, lower panel; Supp. Info. Video Files). A similar effect was observed in 
BAECs upon PGC-1 silencing (Fig. 3A, lower panel; Supp. Info. Video Files). The Figure 3A shows 
only one side of the scrach in order to increase the magnification of the image and therefore be able to 
visualize how the cells spread out into the gap. In the images can be appreciated that cell density is 
lower when PGC-1 is absent or reduced while it is higher in over-expressing cells. This is not due to 
differences in confluency, all cultures were 100% confluent, but is mainly attributable to the bigger 
size (about 50%) of PGC-1 deficient cells (Fig. 2D). Nevertheless, PGC-1-/- fully-confuent cultures 
always show small gaps between cells (Fig. 2D), these could be attribute to problems in the formation 
of cell-cell contacts. 
 
Figure 3. Lack of PGC-1 results in reduced intercellular junction/coordination during migration, and 
failure to form angiotubes in vitro. A) Scratch assays of BAECs infected with the indicated adenovirus to 
knock-down PGC-1, and wild-type or PGC-1-/- MLECs. The migratory front is highlighted with a white line 
(n=6). B) In vitro angiotube assay on Matrigel using BAECs silenced for PGC-1 (upper panel), and wild-type 
and PGC-1-/- MLECs (lower panel) (n=5). C) Endothelial cells sprouting from aorta explants from wild-tpe and 
PGC-1-/- mice. Bright field images were taken after 5 days, the lower panels show higher magnification images 
of tip cells from the migratory edge (n=6). Data are means +SD (*) p ≤ 0.05 vs. control. 
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Absence of PGC-1 results in impaired angiotube formation 
The ability to form stable cell-to-cell contacts is not only important to ensure organized cell migration, 
it is also critical for the formation and stabilization of the newly formed vessel. Thus, we next tested 
vessel formation using an in vitro angiotube formation assay. Interestingly, results from silencing of 
PGC-1 expression in BAECs (Fig. 3B upper panel) and the absence of PGC-1 in MLECs (Fig. 3B 
lower panel), showed that both approaches led to an almost complete inability of ECs to form 
angiotubes in vitro, even though cells migrated and aggregated. This result suggested that deficient 
interactions of intercellular junctions provoked by the absence of PGC-1 are likely to be crucial for 
in vivo formation of blood vessels. 
 
PGC-1-/- endothelial cells display an enhanced tip phenotype  
In a complementary approach to test EC migration and intercellular junction interactions in 
combination, we utilized an ex vivo angiogenesis assay using Matrigel-embedded aortic ring explants. 
We found that even in the absence of VEGF-A, PGC-1-/- ECs had the capacity to migrate, while 
wild-type ECs could not migrate unless VEGF-A was added to the medium, and then did so in an 
individual manner, in the absence of interacting cells (Fig. 3C, upper panel). Moreover, we observed 
that, in the presence of VEGF-A, the cellular “chords” of sprouting cells exiting the aortic rings from 
PGC-1-/- mice appeared thinner than those sprouting from wild-type aortic rings. Upon closer 
inspection of migratory edges, we observed that while wild-type ECs where closely packed, in several 
cell-wide chords, with filopodia only in the outermost migratory edge, PGC-1-/- cells formed single-
cell chords, and were highly elongated with extensive filopodia (Fig. 3C, lower panel). These 
observations suggested that in the absence of PGC-1 endothelial cells can migrate even in the 
absence of VEGF and they do not respond normally to VEGF-A, possibly inducing an enhanced tip-
like phenotype. 
 
PGC-1-/- endothelial cells respond to antioxidant treatment enhancing VEGF-A signaling 
Our previous in vitro results indicated that PGC-1-/- MLECs exhibited a greater migration capacity 
compared with wild-type cells due to an overproduction of hydrogen peroxide [14]. Indeed, hydrogen 
peroxide is acknowledged as an important player in angiogenesis [18] and mediate EC migration and 
proliferation [23]. Thus, we evaluated whether the angiogenesis defects found in PGC-1-/- mice could 
be attributed to an excess production of hydrogen peroxide. To this end, we treated PGC-1-/- MLECs 
with an antioxidant and measured their ability to form angiotubes in vitro. Pre-incubation of PGC-1-/- 
MLECs with EUK-189, a synthetic superoxide dismutase/catalase mimetic, enhanced the formation of 
angiotubes (Fig. 4, Supp. Fig. 2), pointing to a participation of hydrogen peroxide in capillary 
formation. To elucidate the molecular mechanisms that could link elevated hydrogen peroxide levels 
with the vascular instability observed in PGC-1-/- mice, we next analyzed the response of wild-type 
and PGC-1-/- MLECs to VEGF-A. This signaling pathway has been suggested previously to be highly 
sensitive to hydrogen peroxide [17, 18]. Consistently, PGC-1-/- MLEC showed increased levels of 
phosphorylated VEGFR2, phosphorylated AKT and greater levels of NICD, compared with wild-type 
cells in the absence of VEGF-A (Fig. 5). Furthermore, relative to wild-type cells, the response to 
VEGF-A treatment was very poor in PGC-1-/- MLECs in terms of VEGFR-2 induced 
phosphorylation, supporting the notion that PGC-1-deleted ECs are largely insensitive to VEGF-A 
activation. Importantly, when PGC-1-/- MLECs were pre-incubated with EUK-189, the response to 
VEGF-A was partially recovered, while the basal levels of phosphorylated VEGFR2, phosphorylated 
AKT and NICD, were reduced (Fig. 5). This observation is consistent with previous reports 
demonstrating the sensitivity of VEGFR-2 and its phosphatases to hydrogen peroxide [17, 18]. 
Moreover, these findings indicate that the response of VEGFR2 to VEGF-A requires the tight control 
of intracellular hydrogen peroxide levels. This control may be lost when important metabolic 
regulators such as PGC-1 are largely inactive [3]. mRNA levels where not significantly affected by 
EU-189 (Suppl. Fig. 3). 
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Figure 4. Antioxidant treatment improves in vitro angiotube formation in PGC-1-/- MLECs. A) In vitro 
angiotube assay on Matrigel using PGC-1-/- MLECs, treated with VEGF and/or EUK-189 (n=3). B) Analysis of 
structures formed in the angitube assay. Data are means +SD (*) p ≤ 0.05 vs. control. 
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Figure 5. Antioxidant treatment restores VEGF signaling in PGC-1-/- MLECs. PGC-1-/- MLECs where 
treated with VEGF and/or EUK-189 for the indicated time periods. Western blot analysis of whole cell extracts 
of relevant proteins in VEGF signaling: VEGFR2, NICD and AKT (n=3). Data are means ±SD (*) p ≤ 0.05 vs. 
control. 
 
PGC-1 has been shown to induce the expression of several mitochondrial antioxidant proteins, and 
its absence results in enhanced mitochondrial superoxide levels. Concomitantly, PGC-1 also 
regulates the expression of important extra-mitochondrial antioxidants, like catalase. In order to 
validate the contribution of mitochondrial ROS to the observed alteration in VEGF signaling, we 
treated PGC-1-/- MLEC with a mitochondria-targeted SOD mimetic, MitoTEMPO and evaluated the 
effect on VEGF-A signaling. We found a significant reduction in the basal levels of phosphorylation 
of VEGFR2 and AKT, as well as a reduction in the basal levels of NICD (Fig. 6A, central panel). 
VEGF-A treatment also resulted in an enhanced fold induction of VEGFR2 and AKT phosphorylation, 
as well as in the levels of NICD upon stimulation (Fig. 6A, bottom panel). These results suggest that 
there is a relevant contribution of mitochondrial ROS production to the observed phenotype. 
 
Finally, since hydrogen peroxide dependent inactivation of VEGF signaling pathway has been 
proposed to be mediated by NOX activity, we tested whether NOX inhibition would be able to restore 
VEGF-A signaling in PGC-1-/- cells, and we found that pretreatment with the general NOX inhibitor 
VAS-2870 also resulted in significant reduction in the basal levels of phosphorylation of VEGFR2 and 
AKT and an enhanced sensitivity (fold induction) of the VEGFR2 receptor to VEGF-A dependent 
phosphorylation, that correlated with and enhanced AKT phosphorylation, supporting the involvement 
of NOX activity (Fig. 6B). 
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Figure 6. Both detoxification of mitochondrial ROS and NOX inhibition restores VEGF signaling in PGC-
1-/- MLECs. PGC-1-/- MLECs where pre-treated with the mitochondria-targeted SOD mimetic MitoTEMPO 
(10 M) for 3 h (A, n=5) or with a general NOX inhibitor (VAS-2870, 20 M) for 2h (B, n=3), then VEGF-A 
was added and downstream signaling (VEGFR2, NICD and AKT) was analyzed by western blot (n=5). Top 
panels show representative western blots. Central panels show the quantitative analysis of data at time 0, prior to 
VEGF-A addition. The bottom panels show the fold induction upon VEGF-A addition, values are normalized for 
those at time 0, that have been assigned the arbitrary value of 1. Data are means ±SD (*) p ≤ 0.05 vs. control. 
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Discussion 
 
The results of this study show that regulation of ROS homeostasis by PGC-1 plays an important role 
in the control of endothelial function, in particular in the regulation by VEGF-A of the stability of the 
cellular and cellular-matrix contacts. We demonstrate that, in the absence of PGC-1, the vascular 
endothelial cells appears to be constitutively activated, characterized by faster migrating ECs which 
adhere slowly to the substrate. Also, ECs spread slowly and can reverse this process and detach again. 
These alterations are likely due to the low stability and high turnover of the focal adhesions, an 
inability to form a structured f-actin cytoskeleton, and a reduced formation of VE-cadherin adherens 
junctions. Succinctly, ECs interact poorly with the substrate and with other cells. Clearly, these 
alterations are likely to be relevant in metabolic disorders where PGC-1 activity is generally found to 
be low, and in particular might be related to the development of diabetic retinopathy. 
 
Reduced intercellular contacts in PGC-1-deficient ECs resulted in the loss of coordinated cell 
movement in scratch assays, and a failure to form angiotubes in vitro. Analysis of the endothelial 
sprouting process from aortic rings further suggested that PGC-1-deficient cells actively migrate 
even in the absence of VEGF-A, and form tip cells independently of their location, indicating a 
defective response to VEGF-A. Treatment of MLECs with VEGF-A in vitro, together with analysis of 
the VEGF pathway, confirmed that the absence of PGC-1 resulted in the constitutive activation of 
the VEGF-A signaling pathway, plus a poor response to exogenous VEGF-A. This defective response 
to VEGF-A may explain the constitutively-activated phenotype of PGC-1 deficient ECs. 
 
PGC-1 deficient ECs have elevated levels of oxygen superoxide and hydrogen peroxide [5]. Given 
that the VEGF-A signaling pathway has been shown to be sensitive to hydrogen peroxide, and that 
oxidative modifications of VEGFR2 [18, 24] and its main phosphatases have been described [17], we 
hypothesized that elevated ROS levels found in PGC-1-deficient ECs would be responsible for the 
poor VEGF-A response. Consistent with this idea, we found that antioxidant treatment largely restored 
normal VEGF-A response in PGC-1 deficient ECs. Furthermore, EUK-189 treatment also restored 
the capacity of those cells to form angiotubes in vitro, indicating a normalization of the inter-cellular 
interactions.  
 
Long regarded as by-products of oxidative metabolism, ROS are now recognized as signaling 
mediators in their own right. The prototypic redox-regulated targets are the protein tyrosine 
phosphatases that are inactivated by hydrogen peroxide; however, identification of redox-sensitive 
kinases such as Src has led to the slow emergence of a role for redox regulation of tyrosine kinases by 
concurrent oxidative activation of tyrosine kinases. Thus, ROS fine-tune the duration and 
amplification of the phosphorylation signal. Importantly, the activity of VEGFR2 and two of its 
phosphatases, DEP1 and PTP1B, have been shown to be regulated by hydrogen peroxide [17] [24] 
[18]. Demonstration of the physiological relevance of these regulations has been hampered by the lack 
of relevant disease models, since the majority of experimental evidence derives from in vitro assays 
with artificially generated or exogenously added ROS; this is the case for VEGFR-2 signaling 
pathways. 
 
PGC-1 is known to regulate the levels of mitochondrial ROS [5]. However, most recent studies stress 
the role played by NADPH oxidases (NOXs) in the ROS-dependent control of growth factor signaling 
processes [25] and less attention has been paid to the role of mitochondrial ROS. Nevertheless, 
although a largely neglected area of research, a body of evidence shows that elevated mitochondrial 
production of ROS is commonly found in cells with elevated NOX activity, and it has been shown that 
mitochondria can regulate NOX function and viceversa [26]. Additionally, most, if not all, 
physiological settings where ROS appear to play an important role, including angiogenesis, describe 
both enhanced NOX and elevated mitochondrial ROS levels [27, 28]. Furthermore, mitochondria-
targeted antioxidants have been proposed to have potential therapeutic value in retinopathy [29]. 
Nonetheless, it remains to be determined whether PGC-1 could also directly regulate the expression 
or activity of NOX or alternatively of PrxII, the peroxiredoxin antioxidant that appears to modulate 
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VEGFR2 oxidation [18]. 
 
In conclusion, our study strongly supports the idea that PGC-1 control of hydrogen peroxide levels in 
endothelial cells plays a major role in the formation of stable interactions of endothelial cells with 
other cells and with the matrix, a process likely to be relevant in metabolic disorders where 
microvascular complications are prevalent, like diabetic retinopathy. Since antioxidant therapies have 
shown significant caveats, alternative therapies that aim to re-wire normal ROS homeostasis, boosting 
PGC-1 activity might represent a therapeutic approach for retinopathy patients.  
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Abstract 
 
Peroxisome proliferator activated receptor  co-activator 1 (PGC-1) is a regulator of mitochondrial 
metabolism and reactive oxygen species (ROS) that is known to play a relevant role in angiogenesis. 
Aims: This study aims to investigate the role of ROS on the regulation by PGC-1 of angiogenesis. 
Methods and Results: We found that endothelial cells (ECs) from mice deleted for PGC-1 display 
attenuated adhesion to the extracellular matrix, together with slower and reversible spreading. 
Structural analysis demonstrates unstable formation of focal adhesions, defective cytoskeleton 
reorganization in response to cellular matrix adhesion, cell migration and cell-cell adhesion. Confluent 
cultures showed also a reduction of membrane bound VE-cadherin, suggesting defective inter-cellular 
junction formation. Functional consequences included impaired directional migration, and enhanced 
tip phenotype in aortic explants sprouting assays. At the molecular level, PGC-1-deleted ECs exhibit 
a constitutive activation of the vascular endothelial growth factor-A (VEGF-A) signaling pathway and 
a defective response to VEGF-A. All these alterations are partially reversed by administration of the 
antioxidant EUK-189. The contribution of mitochondrial ROS and NOX activation was confirmed 
using a mitochondrial targeted antioxidant (MitoTEMPO) and a NOX inhibitor (VAS-2870). These 
results indicate that elevated production of ROS in the absence of PGC-1 is a key factor in the 
alteration of the VEGF-A signaling pathway and the capacity of endothelial cells to form stable 
interactions with other endothelial cells and with the extracellular matrix. Our findings show that 
PGC-1 control of ROS homeostasis plays an important role in the control of endothelial response to 
VEGF-A. 
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Introduction 
 
While caloric restriction boost in the organism the use of mitochondria as a source of ATP, 
overfeeding tends to decrease the use of mitochondria as a source of ATP and leads to a 
preponderance of anaerobic glycolysis in a variety of tissues [1, 2]. This decrease in mitochondrial 
function is mediated by the down-regulation and functional inactivation of key metabolic regulators 
like the transcriptional coactivator Peroxisome proliferator-activated receptor gamma coactivator-1-
alpha (PGC-1) [3, 4], a master regulator of genes involved in oxidative metabolism. Loss of PGC-1 
activity results in an increase of mitochondrial-derived reactive oxygen species (ROS) [5], and 
elevated ROS levels (oxidative stress) have been found in the majority of vascular complications 
associated with metabolic disorders.  
 
The importance of protecting the body from the most common metabolic disorders, including obesity 
and type 2 diabetes cannot be overstated, and their prevalence continues to increase yearly and World-
wide. Dysfunctions of the human vascular tree are the major source of morbidity and mortality. 
Generally, the damaging effects can be separated into macrovascular (coronary artery disease, 
peripheral arterial disease, and stroke) and microvascular (nephropathy, neuropathy, and retinopathy) 
injury [6]. Diabetic retinopathy is one of the most common microvascular complications of diabetes, 
and is a leading cause of ∼10,000 new cases of blindness every year in the United States alone [7].  
 
Reduced mitochondrial activity has been amply reported as a hallmark of type 2 diabetes [8, 9] and 
reduced activity of PGC-1 in diabetic subjects has been show in several tissues including the skeletal 
muscle [2]. However, elevated mRNA levels of PGC-1 have been found in the liver of type 2 
diabetic subjects and it has been proposed that elevated PGC-1 in diabetic subjects increases 
gluconeogenesis pointing to a putative detrimental role of PGC-1 in type 2 diabetes. More recently, it 
has also been proposed that PGC-1 activation in the retina may be involved in type 2 diabetic 
retinopathy, through the induction of VEGF-A levels [10, 11]. 
 
Previous results from our group showed that PGC-1 was present in vascular endothelial cells (ECs), 
and its levels were reduced by hyperglycemia. Furthermore, PGC-1 could coordinate ECs oxidative 
metabolism and antioxidant capacity [12], suggesting that PGC-1 could play a key role in the 
physiology of the vascular endothelium. ROS (ie hydrogen peroxide) are acknowledged as important 
signaling mediators regulating cell proliferation and migration [13]. Additional studies from our 
laboratory showed that, at least in vitro, PGC-1 was a negative regulator of EC migration indicating 
that PGC-1 activity could be important for the control of vascular stability and angiogenesis. 
Accordingly, in response to angiogenesis mediators, PI3K-AKT activation resulted in the down-
regulation of PGC-1 leading to increased mitochondrial ROS levels (oxygen superoxide and 
hydrogen peroxide) and enhanced EC migration [14]. More recently, it has been shown that PGC-1 
deficient mice show defective induction of VEGF-A in response to ischemia and impaired 
angiogenesis [15, 16]. However, the molecular mechanisms involved, other than altered endothelial 
cell migration where largely unknown. Importantly, hydrogen peroxide is increasingly recognized as a 
regulator of VEGF-A signaling [17, 18]. Since VEGF-A activity is a crucial factor in the regulation of 
endothelial motility and interaction with other cells and with the basal membrane. In this study we 
aimed to characterize the role of PGC-1 as a regulator of ROS homeostasis in the control of 
endothelial adhesion dynamics and VEGF-A signaling. 
 
We found that ECs deleted for PGC-1 had a reduced capacity to interact with each other and with the 
extracellular matrix, and were unable to form angiotubes in vitro. Furthermore, PGC-1 deleted ECs 
moved faster but in a non-coordinated manner, and displayed a tip-like phenotype. Importantly, their 
response to VEGF-A was impaired. These characteristics would be consistent with a reduced capacity 
to form a stable vasculature. Crucially, this phenotype could be partially rescued by antioxidant 
treatment, suggesting that excessive hydrogen peroxide production is likely to play an important role 
in vascular stability. 
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Material and Methods 
 
Animal handling. C57BL6 PGC-1+/+ and PGC-1-/- were used. C57BL/6 PGC-1-/- mice were 
originally provided by Dr. Bruce Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School) 
and following embryo transfer, a colony was established at the CNIC and IIB SPF animal facilities. 
Animal experimental protocols were approved by the Institutional Animal Care and Use Committee of 
the CNIC (N
o
 PI 19/09) and the CSIC (SAF2012-37693). All procedures conformed to the Declaration 
of Helsinki and the NIH guidelines for animal care and use (NIH publication No. 85-23). Animals 
were maintained at a constant temperature of 21+/- 1°C and on a 12-hour light–dark cycle. Animal 
experimental protocols were approved by the Institutional Animal Care and Use Committee of the 
CNIC and the CSIC. All procedures conformed to the Declaration of Helsinki and the NIH guidelines 
for animal care and use (NIH publication No. 85-23). Mice were euthanized by carbon dioxide 
inhalation or cervical dislocation. 
 
Cell culture. Bovine Aortic Endothelial Cells (BAECs) and Mouse Lung Endothelial Cells (MLECs) 
were obtained and cultured as described [14]. Bovine Aortas were obtained from an authorized 
slaughterhouse (El Matadero S.C.M., Colmenar Viejo, Madrid, Spain). Adenovirus overexpression 
and infection protocols have been described [19]. 
 
Cell-attachment and cell spreading assays. Experiments were performed in triplicate in 96-well plates. 
Wells were coated with fibronectin (1 µg/ml, Sigma) or collagen I (30 g/ml, INAMEN Biomaterials) 
and then blocked for 90 minutes with 1% heat-denatured BSA in PBS. MLECs were plated at 9x10
4
 
cells/well for up to 1 hour, washed, fixed with 3% PFA for 1 min, permeabilized with 2% methanol 
for 3 min, stained with 0.5 % crystal violet in 20 % methanol for 2 min, washed with water and 
examined by brightfield microscopy (Nikon Eclipse 90Ti with objectives: Plan Fluor 4x/0.13 Ph1 DL, 
Plan Fluor 10x/0.30 Ph1 DLL, Plan Fluor ELWD 40x/0.60 Ph2 DH). Cells were classified as spread if 
the nucleus and cytoplasmic extensions were distinguishable.  
 
Time lapse video imaging of scratch assays. Scratch assays were performed as previously described 
[14], and images were taken every 20 min for up to 30 h with a Nikon Eclipse Ti microscope 
(objective 4x). 
 
Sprouting angiogenesis on aortic explants. Assays were performed as described [20]. 
 
Immunofluorescence and phalloidin staining. MLECs grown on coverslips were fixed with 3.6% PFA, 
permeabilized with 0.1% Triton X-100, blocked with 2% BSA and then incubated consecutively with 
primary antibody (-p-paxillin or -VE-cadherin) and a secondary antibody (IgG rabbit ALEXA-
488 conjugate), or stained with FITC-phalloidin (Molecular Probes) in PBS for 1 h. Cells were then 
counterstained with DAPI, mounted and examined with a confocal microscope (Nikon A1R, objective 
40x) for VE-cadherin or a TIRF microscope (Leica, objective HCX Pl Apo 100x 1.46 Oil) for p-
paxilin. 
 
In vitro endothelial cell tube formation. Assays were performed essentially as described[21]. 96-well 
plates were coated with 40 l of growth factor reduced (GFR) BD Matrigel per well. MLECs (17000 
cells) resuspended in 100 l of tissue culture media with 2% Horse Serum (HS) and containing, as 
indicated, 50 ng/ml of VEGF-A, were seeded per well. Images were taken every 20 min for up to 48 h 
with a Nikon EclipseTi microscope. 
 
Vascular Endothelial Growth Factor-A (VEGF-A) treatment. MLECs were grown to confluence in 
DMEM-F12 medium with 20% FBS. Following overnight serum starvation o/n (0.5% FBS) the cells 
were first pre-incubated with 10 M EUK-189 or 20 M VAS-2870 for 2 h, or 10 M MitoTEMPO 
for 3 h as indicated and then incubated with 12.5 ng/ml of VEGF for up to 4 h and harvested. 
 
Protein extraction and Western blotting. Protein extraction was as previously described [19]. Protein 
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extracts 20-25 g of were resolved by electrophoresis in 6-12% SDS-PAGE gels, followed by transfer 
to PVDF Hybond-P membranes (Amersham Biosciences) and incubated with specific antibodies 
against HIF-1 (610958, BD Transduction Laboratories), VEGF-A, (VG-1, Santa Cruz), VEGF-R2 
(55B11, 1:1000), P-VEGFR2 ( 2471, 1:1000), NICD (4147, 1:1000), AKT (2920) and 
phosphorylated AKT-Ser
473
 (4060) (1:2000), all from Cell Signaling Technology®, and -actin (A 
5441, Sigma). -actin was used as a loading control. 
 
Image analysis. ImageJ software was used to analyze western blots, for global determination of areas 
in inmunofluorescent images, and membrane/cytosol ratios of VE-cadherin. In vitro angiogenesis 
images were analyzed using the Angiogenesis Analyzer tool for Image J developed by Gilles 
Carpertier.  
 
Statistics. Data are expressed as means ±SD. Statistical significance was evaluated by analysis of 
variance or a nonparametric test, as appropriate. Values were considered statistically significant at p < 
0.05. n ≥ 3 in all experiments. The number of independent experiments, for each particular 
experiment, is indicated in the corresponding figure legends. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
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PGC-1 enhances endothelial adhesion to the extracellular matrix 
To evaluate the role of PGC-1 during ECs interaction with the extracellular matrix (ECM), MLECs 
obtained from PGC-1-/- and PGC-1+/+ mice were allowed to adhere to collagen I or fibronectin-
coated slides for 30 min and were subsequently counted. These substrates where selected because they 
are the most commonly used substrates for endothelial cells grown in vitro. Compared with wild type 
MLECs, significantly fewer PGC-1-/- MLECs adhered to both fibronectin and collagen I (Fig.1A, top 
panel); although adherence of both was greater to fibronectin than to collagen matrix. To determine 
whether PGC-1-/- MLECs adhered more slowly to ECM or with less stability, a time course analysis 
using fibronectin was performed, and attached cells were counted. At 20 min, the number of wild-type 
MLECs attached reached a maximum while PGC-1-/- MLECs continued to adhere after 30 min (Fig. 
1A, bottom panel), suggesting that matrix attachment might be less efficient in PGC-1-/- MLECs. 
To determine whether the absence of PGC-1 reduced the initial contacts only, or also had an effect 
on the formation of stable interactions with the matrix, we evaluated the cell spreading process by 
determining the number of attached cells that had spread 1 h after plating. Results showed that 
whereas greater than 80 % of wild-type MLECs had spread onto the matrix, approximately 45 % of 
PGC-1-/- MLEC had done so (Fig. 1B), suggesting that PGC-1 deficiency reduced the formation of 
stable adhesions.  
 
Figure 1. Endothelial cell adhesion and spreading dynamics are regulated by PGC-1. Wild-type and PGC-
1-/- MLECs were seeded on plates coated with fibronectin or collagen I and allowed to adhere for up to 30 min 
(A) or to spread for up to 2 h (B). Cells were washed fixed, bright field visualized on a microscope and counted. 
Left panels show images from representative experiments. Right panels show the quantifications. Data are means 
+SD (*) p ≤ 0.05 vs. control. A, top panel) n=9. A, bottom panel) n=8. B) n=6. 
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Absence of PGC-1 results in unstable adhesion and spreading 
To corroborate these results, we monitored the cell adhesion-spreading process using time-lapse video 
imaging of cell movements for 1 h after attachment to collagen I matrix. In contrast to wild-type 
MLECs, which displayed very limited motility after initial spreading, PGC-1-/- MLECs not only 
moved faster once attached, as has been previously described [14], but also showed incomplete and 
fully reversible spreading and detachment (Fig. 2A). Collectively, these results suggest that both the 
initial interaction with the matrix and also the formation of stable focal adhesions may be impaired in 
PGC-1-/- ECs. 
 
To assess whether PGC-1 regulated the formation of focal adhesions, we next analyzed the focal 
adhesion complex-component paxillin. Paxillin is activated and phosphorylated by focal adhesion 
kinase (FAK) in response to integrin signaling, resulting in the formation of a focal adhesion complex. 
However, it must be dephosphorylated to allow the stabilization of the focal adhesion, and therefore 
can be used to monitor the turnover rate of newly formed focal adhesions. Analysis of phospo (p)-
paxillin in MLECs that had been allowed to attach for 30 min, revealed that p-paxillin was localized to 
the tips of spreading filopoidia in wild-type MLECs (Fig. 2B). In contrast, PGC-1-/- MLECs 
displayed intense p-paxillin staining throughout the cell periphery, suggesting a random and highly 
active turnover of focal adhesions. These findings imply that the reduced adhesion capacity of PGC-
1-/- MLECs is not due to an inability to form focal adhesion complexes but rather might be the 
consequence of an excessive FAK activity and high turnover rate [22] 
 
Defective cytoskeleton dynamics in absence of PGC-1 
Cellular interactions with matrix components triggers stress fiber-formation of the polymerized actin 
cytoskeleton. In wild-type MLECs, F-actin was found concentrated in the extending filopodia of 
spreading cells 1 h after plating, and stress fibers were fully formed 2 h following plating (Fig 2B). In 
contrast, MLECs from PGC-1-/- mice exhibited dispersed F-actin foci throughout the cell periphery, 
and no stress fibers were detected even after 2 h (Fig 2B). To determine if this disorganization was a 
consequence of a deficient cell adhesion process, or could also be conspicuous in other situations, we 
analyzed the actin cytoskeleton of migrating and confluent cell cultures. Interestingly, while actin 
filaments reorganized in wild-type cells, and were about 2.5x more concentrated in the leading edge 
than in the retracting edge, this was barely detectable in PGC-1-/- MLECs (Fig. 2C). In confluent 
cultures, actin filaments are normally more concentrated in the cellular periphery than in the cytosol. 
Remarkably, this difference was more marked in PGC-1-/- MLEC, while mean cytosolic phalloiding 
stain was lower PGC-1-/- MLEC (Fig. 2C). These two characteristics could be related to the higher 
mobility of these cells. Moreover, PGC-1-/- MLECs were, on average, approximately 50% larger than 
wild-type counterparts, possibly a consequence of actin disorganization (Fig. 2D). 
 
Endothelial cells show reduced formation of adherens junctions in absence of PGC-1 
To test whether intercellular junctions were also affected by the absence of PGC-1, we analyzed VE-
cadherin staining in confluent cultures. VE-cadherin plays a major role in the organization of 
intercellular adherens junctions in ECs. PGC-1-/- MLECs exhibited a reduction in VE-cadherin levels 
relative to wild-type cells; also, staining was not continuous and gaps could be detected together in 
zones where the membranes were not in direct contact despite the confluence of the culture (Fig. 2D, 
Supp. Fig. 1). 
 
 
 
 
 
 
 
 
 
Fig. 2 
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Figure 2. PGC-1-/- MLEC form unstable cell-matrix and cell-cell contacts. A) Time-lapse bright field video 
images of live cells that have been allowed to adhere for 1 h. Images show the dynamics of representative cells at 
5 min intervals for 1 h (n=3). B) Focal adhesion dynamics was analyzed by IF staining of cells with a p-paxillin 
antibody and polymerized actin filaments with phalloidin. Focal adhesions were visualized using a TIRF 
microscope (n=3). C) Wild-type and PGC-1-/- MLECs actin filaments stained with phalloidin in sub-confluent 
and confluent MLECs and visualized with a fluorescence microscope (n=3). D) IF of VE-cadherin of confluent 
wild-type and PGC-1-/- MLECs on a fibronectin-coated plate. Nuclei were stained with DAPI (n=3). Data are 
means +SD (*) p ≤ 0.05 vs. control. 
PGC-1 regulates endothelial cell coordination during migration 
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To assess how these deficiencies could impact on cell migration processes, we monitored cell motility 
using in vitro scratch assays and time-lapse video imaging. Whereas wild-type cells appeared to 
stream together as they migrated, we noted that the absence of PGC-1 resulted not only in an 
accelerated cell movement as already described [14], but also on a pronounced tendency to disperse 
over a larger area (Fig. 3A, lower panel; Supp. Info. Video Files). A similar effect was observed in 
BAECs upon PGC-1 silencing (Fig. 3A, lower panel; Supp. Info. Video Files). The Figure 3A shows 
only one side of the scrach in order to increase the magnification of the image and therefore be able to 
visualize how the cells spread out into the gap. In the images can be appreciated that cell density is 
lower when PGC-1 is absent or reduced while it is higher in over-expressing cells. This is not due to 
differences in confluency, all cultures were 100% confluent, but is mainly attributable to the bigger 
size (about 50%) of PGC-1 deficient cells (Fig. 2D). Nevertheless, PGC-1-/- fully-confuent cultures 
always show small gaps between cells (Fig. 2D), these could be attribute to problems in the formation 
of cell-cell contacts. 
 
Figure 3. Lack of PGC-1 results in reduced intercellular junction/coordination during migration, and 
failure to form angiotubes in vitro. A) Scratch assays of BAECs infected with the indicated adenovirus to 
knock-down PGC-1, and wild-type or PGC-1-/- MLECs. The migratory front is highlighted with a white line 
(n=6). B) In vitro angiotube assay on Matrigel using BAECs silenced for PGC-1 (upper panel), and wild-type 
and PGC-1-/- MLECs (lower panel) (n=5). C) Endothelial cells sprouting from aorta explants from wild-tpe and 
PGC-1-/- mice. Bright field images were taken after 5 days, the lower panels show higher magnification images 
of tip cells from the migratory edge (n=6). Data are means +SD (*) p ≤ 0.05 vs. control. 
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Absence of PGC-1 results in impaired angiotube formation 
The ability to form stable cell-to-cell contacts is not only important to ensure organized cell migration, 
it is also critical for the formation and stabilization of the newly formed vessel. Thus, we next tested 
vessel formation using an in vitro angiotube formation assay. Interestingly, results from silencing of 
PGC-1 expression in BAECs (Fig. 3B upper panel) and the absence of PGC-1 in MLECs (Fig. 3B 
lower panel), showed that both approaches led to an almost complete inability of ECs to form 
angiotubes in vitro, even though cells migrated and aggregated. This result suggested that deficient 
interactions of intercellular junctions provoked by the absence of PGC-1 are likely to be crucial for 
in vivo formation of blood vessels. 
 
PGC-1-/- endothelial cells display an enhanced tip phenotype  
In a complementary approach to test EC migration and intercellular junction interactions in 
combination, we utilized an ex vivo angiogenesis assay using Matrigel-embedded aortic ring explants. 
We found that even in the absence of VEGF-A, PGC-1-/- ECs had the capacity to migrate, while 
wild-type ECs could not migrate unless VEGF-A was added to the medium, and then did so in an 
individual manner, in the absence of interacting cells (Fig. 3C, upper panel). Moreover, we observed 
that, in the presence of VEGF-A, the cellular “chords” of sprouting cells exiting the aortic rings from 
PGC-1-/- mice appeared thinner than those sprouting from wild-type aortic rings. Upon closer 
inspection of migratory edges, we observed that while wild-type ECs where closely packed, in several 
cell-wide chords, with filopodia only in the outermost migratory edge, PGC-1-/- cells formed single-
cell chords, and were highly elongated with extensive filopodia (Fig. 3C, lower panel). These 
observations suggested that in the absence of PGC-1 endothelial cells can migrate even in the 
absence of VEGF and they do not respond normally to VEGF-A, possibly inducing an enhanced tip-
like phenotype. 
 
PGC-1-/- endothelial cells respond to antioxidant treatment enhancing VEGF-A signaling 
Our previous in vitro results indicated that PGC-1-/- MLECs exhibited a greater migration capacity 
compared with wild-type cells due to an overproduction of hydrogen peroxide [14]. Indeed, hydrogen 
peroxide is acknowledged as an important player in angiogenesis [18] and mediate EC migration and 
proliferation [23]. Thus, we evaluated whether the angiogenesis defects found in PGC-1-/- mice could 
be attributed to an excess production of hydrogen peroxide. To this end, we treated PGC-1-/- MLECs 
with an antioxidant and measured their ability to form angiotubes in vitro. Pre-incubation of PGC-1-/- 
MLECs with EUK-189, a synthetic superoxide dismutase/catalase mimetic, enhanced the formation of 
angiotubes (Fig. 4, Supp. Fig. 2), pointing to a participation of hydrogen peroxide in capillary 
formation. To elucidate the molecular mechanisms that could link elevated hydrogen peroxide levels 
with the vascular instability observed in PGC-1-/- mice, we next analyzed the response of wild-type 
and PGC-1-/- MLECs to VEGF-A. This signaling pathway has been suggested previously to be highly 
sensitive to hydrogen peroxide [17, 18]. Consistently, PGC-1-/- MLEC showed increased levels of 
phosphorylated VEGFR2, phosphorylated AKT and greater levels of NICD, compared with wild-type 
cells in the absence of VEGF-A (Fig. 5). Furthermore, relative to wild-type cells, the response to 
VEGF-A treatment was very poor in PGC-1-/- MLECs in terms of VEGFR-2 induced 
phosphorylation, supporting the notion that PGC-1-deleted ECs are largely insensitive to VEGF-A 
activation. Importantly, when PGC-1-/- MLECs were pre-incubated with EUK-189, the response to 
VEGF-A was partially recovered, while the basal levels of phosphorylated VEGFR2, phosphorylated 
AKT and NICD, were reduced (Fig. 5). This observation is consistent with previous reports 
demonstrating the sensitivity of VEGFR-2 and its phosphatases to hydrogen peroxide [17, 18]. 
Moreover, these findings indicate that the response of VEGFR2 to VEGF-A requires the tight control 
of intracellular hydrogen peroxide levels. This control may be lost when important metabolic 
regulators such as PGC-1 are largely inactive [3]. mRNA levels where not significantly affected by 
EU-189 (Suppl. Fig. 3). 
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Figure 4. Antioxidant treatment improves in vitro angiotube formation in PGC-1-/- MLECs. A) In vitro 
angiotube assay on Matrigel using PGC-1-/- MLECs, treated with VEGF and/or EUK-189 (n=3). B) Analysis of 
structures formed in the angitube assay. Data are means +SD (*) p ≤ 0.05 vs. control. 
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Figure 5. Antioxidant treatment restores VEGF signaling in PGC-1-/- MLECs. PGC-1-/- MLECs where 
treated with VEGF and/or EUK-189 for the indicated time periods. Western blot analysis of whole cell extracts 
of relevant proteins in VEGF signaling: VEGFR2, NICD and AKT (n=3). Data are means ±SD (*) p ≤ 0.05 vs. 
control. 
 
PGC-1 has been shown to induce the expression of several mitochondrial antioxidant proteins, and 
its absence results in enhanced mitochondrial superoxide levels. Concomitantly, PGC-1 also 
regulates the expression of important extra-mitochondrial antioxidants, like catalase. In order to 
validate the contribution of mitochondrial ROS to the observed alteration in VEGF signaling, we 
treated PGC-1-/- MLEC with a mitochondria-targeted SOD mimetic, MitoTEMPO and evaluated the 
effect on VEGF-A signaling. We found a significant reduction in the basal levels of phosphorylation 
of VEGFR2 and AKT, as well as a reduction in the basal levels of NICD (Fig. 6A, central panel). 
VEGF-A treatment also resulted in an enhanced fold induction of VEGFR2 and AKT phosphorylation, 
as well as in the levels of NICD upon stimulation (Fig. 6A, bottom panel). These results suggest that 
there is a relevant contribution of mitochondrial ROS production to the observed phenotype. 
 
Finally, since hydrogen peroxide dependent inactivation of VEGF signaling pathway has been 
proposed to be mediated by NOX activity, we tested whether NOX inhibition would be able to restore 
VEGF-A signaling in PGC-1-/- cells, and we found that pretreatment with the general NOX inhibitor 
VAS-2870 also resulted in significant reduction in the basal levels of phosphorylation of VEGFR2 and 
AKT and an enhanced sensitivity (fold induction) of the VEGFR2 receptor to VEGF-A dependent 
phosphorylation, that correlated with and enhanced AKT phosphorylation, supporting the involvement 
of NOX activity (Fig. 6B). 
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Figure 6. Both detoxification of mitochondrial ROS and NOX inhibition restores VEGF signaling in PGC-
1-/- MLECs. PGC-1-/- MLECs where pre-treated with the mitochondria-targeted SOD mimetic MitoTEMPO 
(10 M) for 3 h (A, n=5) or with a general NOX inhibitor (VAS-2870, 20 M) for 2h (B, n=3), then VEGF-A 
was added and downstream signaling (VEGFR2, NICD and AKT) was analyzed by western blot (n=5). Top 
panels show representative western blots. Central panels show the quantitative analysis of data at time 0, prior to 
VEGF-A addition. The bottom panels show the fold induction upon VEGF-A addition, values are normalized for 
those at time 0, that have been assigned the arbitrary value of 1. Data are means ±SD (*) p ≤ 0.05 vs. control. 
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Discussion 
 
The results of this study show that regulation of ROS homeostasis by PGC-1 plays an important role 
in the control of endothelial function, in particular in the regulation by VEGF-A of the stability of the 
cellular and cellular-matrix contacts. We demonstrate that, in the absence of PGC-1, the vascular 
endothelial cells appears to be constitutively activated, characterized by faster migrating ECs which 
adhere slowly to the substrate. Also, ECs spread slowly and can reverse this process and detach again. 
These alterations are likely due to the low stability and high turnover of the focal adhesions, an 
inability to form a structured f-actin cytoskeleton, and a reduced formation of VE-cadherin adherens 
junctions. Succinctly, ECs interact poorly with the substrate and with other cells. Clearly, these 
alterations are likely to be relevant in metabolic disorders where PGC-1 activity is generally found to 
be low, and in particular might be related to the development of diabetic retinopathy. 
 
Reduced intercellular contacts in PGC-1-deficient ECs resulted in the loss of coordinated cell 
movement in scratch assays, and a failure to form angiotubes in vitro. Analysis of the endothelial 
sprouting process from aortic rings further suggested that PGC-1-deficient cells actively migrate 
even in the absence of VEGF-A, and form tip cells independently of their location, indicating a 
defective response to VEGF-A. Treatment of MLECs with VEGF-A in vitro, together with analysis of 
the VEGF pathway, confirmed that the absence of PGC-1 resulted in the constitutive activation of 
the VEGF-A signaling pathway, plus a poor response to exogenous VEGF-A. This defective response 
to VEGF-A may explain the constitutively-activated phenotype of PGC-1 deficient ECs. 
 
PGC-1 deficient ECs have elevated levels of oxygen superoxide and hydrogen peroxide [5]. Given 
that the VEGF-A signaling pathway has been shown to be sensitive to hydrogen peroxide, and that 
oxidative modifications of VEGFR2 [18, 24] and its main phosphatases have been described [17], we 
hypothesized that elevated ROS levels found in PGC-1-deficient ECs would be responsible for the 
poor VEGF-A response. Consistent with this idea, we found that antioxidant treatment largely restored 
normal VEGF-A response in PGC-1 deficient ECs. Furthermore, EUK-189 treatment also restored 
the capacity of those cells to form angiotubes in vitro, indicating a normalization of the inter-cellular 
interactions.  
 
Long regarded as by-products of oxidative metabolism, ROS are now recognized as signaling 
mediators in their own right. The prototypic redox-regulated targets are the protein tyrosine 
phosphatases that are inactivated by hydrogen peroxide; however, identification of redox-sensitive 
kinases such as Src has led to the slow emergence of a role for redox regulation of tyrosine kinases by 
concurrent oxidative activation of tyrosine kinases. Thus, ROS fine-tune the duration and 
amplification of the phosphorylation signal. Importantly, the activity of VEGFR2 and two of its 
phosphatases, DEP1 and PTP1B, have been shown to be regulated by hydrogen peroxide [17] [24] 
[18]. Demonstration of the physiological relevance of these regulations has been hampered by the lack 
of relevant disease models, since the majority of experimental evidence derives from in vitro assays 
with artificially generated or exogenously added ROS; this is the case for VEGFR-2 signaling 
pathways. 
 
PGC-1 is known to regulate the levels of mitochondrial ROS [5]. However, most recent studies stress 
the role played by NADPH oxidases (NOXs) in the ROS-dependent control of growth factor signaling 
processes [25] and less attention has been paid to the role of mitochondrial ROS. Nevertheless, 
although a largely neglected area of research, a body of evidence shows that elevated mitochondrial 
production of ROS is commonly found in cells with elevated NOX activity, and it has been shown that 
mitochondria can regulate NOX function and viceversa [26]. Additionally, most, if not all, 
physiological settings where ROS appear to play an important role, including angiogenesis, describe 
both enhanced NOX and elevated mitochondrial ROS levels [27, 28]. Furthermore, mitochondria-
targeted antioxidants have been proposed to have potential therapeutic value in retinopathy [29]. 
Nonetheless, it remains to be determined whether PGC-1 could also directly regulate the expression 
or activity of NOX or alternatively of PrxII, the peroxiredoxin antioxidant that appears to modulate 
GARCÍA-QUINTANS ET AL. 
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VEGFR2 oxidation [18]. 
 
In conclusion, our study strongly supports the idea that PGC-1 control of hydrogen peroxide levels in 
endothelial cells plays a major role in the formation of stable interactions of endothelial cells with 
other cells and with the matrix, a process likely to be relevant in metabolic disorders where 
microvascular complications are prevalent, like diabetic retinopathy. Since antioxidant therapies have 
shown significant caveats, alternative therapies that aim to re-wire normal ROS homeostasis, boosting 
PGC-1 activity might represent a therapeutic approach for retinopathy patients.  
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